Great feature on Dr. Raju Tomer's lab and their new tool that can cheaply capture high-level images of brain tissue that were previously only possible to capture with ultra-expensive lab equipment. https://lnkd.in/gpEBpv3z
关于我们
Columbia Technology Ventures is the technology transfer office for Columbia University and a central location for many of the technology development initiatives, entrepreneurial activities, external industry collaborations, and commercially-oriented multidisciplinary technology innovations across the university. CTV’s core mission is to facilitate the transfer of inventions from academic research labs to the market for the benefit of society on a local, national, and global basis. Each year, CTV manages more than 350 invention disclosures, 100 license deals, and 20+ new IP-backed start-ups, involving over 750 inventors across Columbia's campuses. CTV currently has over 1200 patent assets available for licensing, across research fields such as bio, IT, clean tech, devices, big data, nanotechnology, materials science, and more. Columbia Technology Ventures has a particular focus on start-up companies. Over the years, CTV has been involved with launching over 200 companies based on Columbia's technologies. Of these companies, over 40 have received VC funding, with 27 successful acquisitions or IPOs to date. For more information, please visit www.techventures.columbia.edu.
- 网站
-
https://www.techventures.columbia.edu
Columbia Technology Ventures的外部链接
- 所属行业
- 高等教育
- 规模
- 11-50 人
- 总部
- New York，NY
- 类型
- 私人持股
- 创立
- 1982
- 领域
- Technology transfer、licensing、entrepreneurship、patents、start-ups、tech transfer和commercialization
地点
Columbia Technology Ventures员工
-
Josh Knauer
Entrepreneur (two exits) ? Strategic Advisor ? Impact Investor ? Speaker ? Ecosystem Services ? Emerging Technology
-
Eric Rosenblum
Managing Partner at Foothill Ventures (always looking for great start-up founders!)
-
Ramon Felciano
Husband. Father. Founder: Digital Alchemy, QIAGEN Digital Insights, Ingenuity, SUMMIT | Data + Tech + Bio & Health Innovation | Strategic Thinker |…
-
Shreefāl Mehta
动态
-
Great feature on Standard Potential, a startup commercializing Columbia IP!
At the Columbia Electrochemical Energy Center (CEEC), Andrew Wang and his team developed a sodium-ion battery technology designed to reduce the cost of batteries. Now, as co-founder and CEO at Standard Potential, he’s applying his research to build a start-up that could transform the future of energy storage. Read about his journey, and many other scientists-turned-CEOs, in this feature by Chemical & Engineering News: https://lnkd.in/gBVzi3mG
The rocky path from PhD to CEO
cen.acs.org
-
Join HICCC & the Irving Cancer Drug Discovery Program on October 15 for a fireside chat with Jeffrey Settleman from Pfizer, discussing new approaches to cancer treatment and diagnosis. CTV's Executive in Residence Colin Foster will co-moderate the conversation. https://lnkd.in/dRbh8ZQV
-
-
Columbia ranked fifth in Inc. Magazine and Fast Company's list of top 50 institutions revolutionizing entrepreneurship!
Columbia University wins a top 5 spot in Inc. Magazine's Ignition Schools awards, "a ranked and global list of schools with the biggest impact on the businesses and ideas that define the future"! The metrics are based on “tech transfer activity, licensing, venture capital support… and the number of alumni who have founded successful businesses”. This outcome has been a group effort by so many amazing teams across Columbia, including Columbia Entrepreneurship, Innovation, and Design, Columbia Engineering, Columbia Business School, Columbia University Irving Medical Center, Columbia Organization of Rising Entrepreneurs, the undergraduate college, the Provost's office, and of course, our own team at Columbia Technology Ventures. But most importantly, our amazing faculty and student entrepreneurs! Onwards and upwards! Full report here: https://lnkd.in/eP2hJGwk
-
-
The CTV Fellows Program is a globally-recognized Fellowship that gives Columbia graduate students and post-docs hands-on experience working on early stage technology assessments, writing marketing abstracts, and preparing marketing campaigns. Apply by Oct. 2: https://lnkd.in/gehH4z6
CTV Fellows Program
techventures.columbia.edu
-
Apply by Nov. 1!
Are you part of an early-stage team with innovative solutions in smart cities or related fields? Apply now to join the Spring 2025 cohort of the 10-week NSF Engineering Center for Smart Streetscapes VALIDATE Accelerator!?[Due: November 1st, 2024] Link: https://lnkd.in/eMyqGNi4 Columbia University is partnering with other CS3 institutions (Florida Atlantic University, Lehman College, Rutgers University, and the University of Central Florida) to offer early stage teams a customized program with education from industry and academic research experts, hands-on value-added workshops, active mentoring, and venture creation opportunities. Through our two-part module, teams will be exposed to the Lean Launchpad methodology through Columbia Engineering’s NSF I-Corp StartMeUp Bootcamp as well as Smart Cities-specific knowledge. Program Timeline: Late January through April 2025 Learn more and apply by November 1st, 2024: https://lnkd.in/eMyqGNi4 For more information about StartMeUp Bootcamp: https://lnkd.in/eu6Jz-m #CS3 #accelerator #innovation #startups #smartcities #emergingtechnology #streetscape #icorp National Science Foundation (NSF)
-
-
Congratulations to Columbia's Dr. Carol Troy, winner of a 2024 XSeed Award! She received a $250,000 grant for her work to develop the first noninvasive treatment for retinal vascular occlusion. Cure. https://lnkd.in/ei3uF7tm
Troy, Giannakakou Named 2024 XSeed Award Winners
wewillcure.com
-
On Sept. 25, learn about the XPRIZE carbon removal final 20 teams, hosted by the Tamer Institute for Social Enterprise and Climate Change at Columbia University . Register here: https://lnkd.in/geK624yM
XPrize Carbon Removal Presentation with Technical Lead, Michael Leitch [NYC Climate Week]
groups.gsb.columbia.edu
-
CTV's latest newsletter is out today, highlighting the Columbia location of Alexandria LaunchLabs! https://lnkd.in/gM_-h63w
-
Congratulations to Columbia's Dr. Gary W. Miller and Dr. David Sulzer on being selected for the 2024 SPARK NS Parkinson’s Disease Translational Research Program, a two-year immersive program designed to advance academic discoveries in Parkinson’s disease from the lab to the clinic!
SPARK NS today announced the five projects that will receive up to $10 million to advance academic discoveries in Parkinson’s Disease from the lab to the clinic. The projects were selected to participate in the SPARK NS 2024 Parkinson’s Disease Translational Research Program, an immersive two-year program designed to help academic research teams improve the odds their promising therapeutics will make it to market and benefit patients. Said Daria Mochly-Rosen, PhD,?a Board Director and Chief Scientific and Education Advisor of SPARK NS, “Funding is essential, but it’s not enough. SPARK NS programs provide comprehensive resources and collaborative experiences that prepare academic researchers for the challenging process of drug development.” Stephen Kargotich, PhD, MBA, LLB, Executive Director of SPARK NS, said of the projects,?“These are stellar examples of the work being done in the Parkinson’s disease research community. SPARK NS plans to launch a new program each year to ensure the translation of more academic discoveries into therapies that improve the quality of life for the millions of people around the world with Parkinson’s and other neurological disorders.” The projects announced today are participating in our 2024 program, which is already underway. SPARK NS is in the process of reviewing applications submitted for our 2025 program and will notify finalists on August 23, 2024. We plan to issue a Call for Proposals for our 2026 program in April 2025. For information on the five projects and their principal investigators, visit the SPARK NS website here: https://lnkd.in/g54rDPqd? To view our press release, go click here: https://lnkd.in/gkCmEZii The photo included in this post is of the principal Investigators for the five projects. From left to right, they are Gary W. Miller PhD, Columbia University; David Sulzer, PhD, Columbia University; Matthew D. Disney, PhD, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology (University of Florida); Alice S. Chen-Plotkin, MD, University of Pennsylvania; and James H. Hurley, PhD, University of California, Berkeley.
-